|
Market Closed -
Nasdaq
00:00:00 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 157.37 USD | +2.49% |
|
+6.98% | +28.21% |
| 10-15 | Goldman Sachs Adjusts Price Target on Gilead Sciences to $142 From $135 | MT |
| 10-14 | Vir Biotechnology Shares Jump on Gilead Cancer Collaboration | DJ |
| Market Cap | 195B 174B 162B 147B 277B 18,482B 282B 1,945B 761B 9,643B 732B 717B 30,857B | P/E 2026 * |
-46x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 216B 193B 180B 163B 307B 20,497B 313B 2,157B 844B 10,694B 812B 795B 34,221B | EV / Sales 2026 * |
7.04x | EV / Sales 2027 * | 6.36x |
| Free-Float |
99.89% | Yield 2026 * |
2.1% | Yield 2027 * | 2.13% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Xetra
| GIS | Delayed | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
Börse Stuttgart
| GIS | Delayed | |
|
London S.E.
| 0QYQ | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.10% | ||
| 1 week | +6.98% | ||
| Current month | +5.58% | ||
| 1 month | +7.57% | ||
| 3 months | +19.49% | ||
| 6 months | +12.59% | ||
| Current year | +28.21% |
| 1 week | 147.26 |  | 160.51 |
| 1 month | 142.6 | | 160.51 |
| Current year | 116.88 | | 160.51 |
| 1 year | 114.02 | | 160.51 |
| 3 years | 62.07 | | 160.51 |
| 5 years | 57.16 | | 160.51 |
| 10 years | 56.56 | | 160.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 22/09/26 | Exercice | Controller/Auditor | 5,214 | 0.0004% | ||
| 15/09/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.49% | +6.98% | +33.03% | +102.67% | 195B | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,116B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 610B | |
| -0.03% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 358B | |
| -0.78% | +5.48% | +32.28% | +49.67% | 366B | |
| -1.31% | +4.40% | +19.17% | +42.59% | 288B | |
| -1.65% | +3.99% | -0.61% | +13.72% | 261B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 235B | |
| -0.95% | +2.17% | -28.74% | -63.11% | 175B | |
| Average | +0.01% | +5.28% | +28.29% | +49.64% | 410.44B | |
| Weighted average by Cap. | +0.35% | +4.95% | +35.39% | +65.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.73B 27.43B 25.49B 23.19B 43.62B 2,910B 44.41B 306B 120B 1,519B 115B 113B 4,859B | 32.84B 29.31B 27.24B 24.78B 46.62B 3,111B 47.47B 327B 128B 1,623B 123B 121B 5,193B |
| Net income | -4.26B -3.8B -3.53B -3.21B -6.04B -403B -6.15B -42.42B -16.6B -210B -15.97B -15.64B -673B | 10.27B 9.17B 8.52B 7.75B 14.58B 973B 14.84B 102B 40.04B 507B 38.53B 37.72B 1,624B |
| Net Debt | 21.27B 18.99B 17.65B 16.05B 30.2B 2,015B 30.74B 212B 82.94B 1,051B 79.83B 78.14B 3,364B | 13.62B 12.16B 11.3B 10.28B 19.34B 1,290B 19.68B 136B 53.1B 673B 51.11B 50.03B 2,154B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $157.37 | +2.49% | 8,288,267 |
| 14/10/26 | $153.54 | +3.80% | 5,761,035 |
| 13/10/26 | $147.92 | -1.67% | 5,558,196 |
| 12/10/26 | $150.43 | -0.49% | 5,792,190 |
| 09/10/26 | $151.17 | +2.77% | 5,802,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
